James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 8,040 shares at $15.94 ($128K) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Seasonal sale ($128k) by EVP & Chief Financial Officer — this insider has traded VNDA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.94 | 4,020 | $64K | 50.0% |
| 2 | $15.94 | 4,020 | $64K | 50.0% |
| Total | $15.94 avg | 8,040 | $128K | 100% |
| Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |
| VNDA | SELL | 2018-03-02 | $319K | — | Filing → |